Cargando…
Pancreatic Transdifferentiation and Glucose-Regulated Production of Human Insulin in the H4IIE Rat Liver Cell Line
Due to the limitations of current treatment regimes, gene therapy is a promising strategy being explored to correct blood glucose concentrations in diabetic patients. In the current study, we used a retroviral vector to deliver either the human insulin gene alone, the rat NeuroD1 gene alone, or the...
Autores principales: | Ren, Binhai, Tao, Chang, Swan, Margaret Anne, Joachim, Nichole, Martiniello-Wilks, Rosetta, Nassif, Najah T., O’Brien, Bronwyn A., Simpson, Ann M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848990/ https://www.ncbi.nlm.nih.gov/pubmed/27070593 http://dx.doi.org/10.3390/ijms17040534 |
Ejemplares similares
-
Ex Vivo Expansion of Murine MSC Impairs Transcription Factor-Induced Differentiation into Pancreatic β-Cells
por: Gerace, Dario, et al.
Publicado: (2019) -
Pancreatic Transdifferentiation Using β-Cell Transcription Factors for Type 1 Diabetes Treatment
por: Mahoney, Alexandra L. G., et al.
Publicado: (2022) -
CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?
por: Gerace, Dario, et al.
Publicado: (2017) -
Reversal of diabetes following transplantation of an insulin-secreting human liver cell line: Melligen cells
por: Lawandi, Janet, et al.
Publicado: (2015) -
Use of a Hybrid Adeno-Associated Viral Vector Transposon System to Deliver the Insulin Gene to Diabetic NOD Mice
por: La, Que T., et al.
Publicado: (2020)